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a b s t r a c t
There is little information on the diverse infectious causes of jaundice and hepatitis in the
Asiatic tropics. Serology (hepatitis A, B, C and E, leptospirosis, dengue, rickettsia), antigen
tests (dengue), PCR assays (hepatitis A, C and E) and blood cultures (septicaemia) were
performed on samples from 392 patients admitted with jaundice or raised transaminases
(≥×3) to Mahosot Hospital, Vientiane, Laos over 3 years. Conservative deﬁnitions sug-
gested diagnoses of dengue (8.4%), rickettsioses (7.3%), leptospirosis (6.8%), hepatitis B
(4.9%), hepatitis C (4.9%), community-acquired septicaemia (3.3%) and hepatitis E (1.6%).
Although anti-hepatitis A virus (HAV) IgM antibody results suggested that 35.8% of patients
had acute HAV infections, anti-HAV IgG antibody avidity and HAV PCR suggested that 82%ickettsia typhi
eptospirosis
aos
had polyclonal activation and not acute HAV infections. Scrub typhus, murine typhus or
leptospirosis were present in 12.8% of patients and were associated with meningism and
relatively lowASTandALTelevation. Thesepatientswouldbeexpected to respond toempir-
ical doxycycline therapy which, in the absence of virological diagnosis and treatment, may
be an appropriate cost-effective intervention in Lao patients with jaundice/hepatitis.
Society© 2010 Royal∗ Corresponding author. Tel.: +856 21 242168; fax: +856 21 242168.
E-mail address: paul@tropmedres.ac (P.N. Newton).
035-9203/$ – see front matter © 2010 Royal Society of Tropical Medicine and H
oi:10.1016/j.trstmh.2010.03.002of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All
rights reserved.
1. IntroductionPatients with biochemical liver impairment and an
infective aetiology are commonly admitted to hospital in
the tropics with a multitude of causes that may be difﬁ-
cult to distinguish. In Southeast Asia the aetiology includes
ygiene. Published by Elsevier Ltd. All rights reserved.
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pathogens such as hepatitis A, B, C and E, dengue, lep-
tospirosis, typhus and those causing septicaemia.1,2 Recent
work in Vientiane, Lao PDR (Laos), has emphasised the
importance of Salmonella enterica serovar typhi, scrub
typhus (Orientia tsutsugamushi) and murine typhus (Rick-
ettsia typhi) as causes of fever.3,4 A study of the aetiology
of jaundice and dark urine among 280 patients admitted
to Vientiane hospitals gave evidence of acute hepatitis A
virus (HAV) and B virus (HBV) infection in 14% and 10%
of cases, respectively.1 Among Vientiane blood donors the
prevalences of hepatitis B surface antigen (HBsAg) and
anti-hepatitis C virus (HCV) antibody were 8.7% and 1.1%,
respectively.5
Whilst investigating the causes of fever among hospi-
talized patients in Vientiane a substantial proportion were
jaundiced or had raised transaminases. Most studies of
the causes of jaundice or hepatitis have concentrated on
a narrow range of pathogens, for example the hepatitis
viruses, in one population and not cast the diagnostic net
broad to includeviruses, rickettsia, leptospires and conven-
tionally culturable bacteria. We therefore investigated the
aetiology amongst inpatients to try to capture the diver-
sity of organisms responsible. As serological tests may not
be sufﬁciently speciﬁc in populations with multiple poten-
tial etiologies because of the persistence of antibody, we
endeavored to determine the aetiology using speciﬁc tests
based on rises in antibody titre between acute and conva-
lescent samples and antigen and PCR assays.
2. Patients and methods
2.1. Study site and patients
The study was conducted at Mahosot Hospital, Vien-
tiane, a 400-bed primary-tertiary hospital with approxi-
mately 1200 admissions/month. This, alongwith four other
major hospitals of 1210 beds, and local hospitals, serves
a population of approximately 900 000 people, including
the urban population of Vientiane City and surrounding
farming communities of Vientiane Province, and, less fre-
quently, outlying provinces.
Patients of any age admitted to Mahosot Hospital with
acute jaundice or elevated AST or ALT (by ≥3 times the
upper limit of the reference range) who gave informed
verbal consent were recruited (May 2001–May 2004) on
eight adult and paediatric wards (192 beds). Blood sam-
ples were taken for admission and convalescent sera and,
if community-acquired septicaemia was suspected, for a
pair of blood cultures.3 If the patient came from an area of
Laos with endemic malaria, Giemsa-stained malaria thick
and thin ﬁlms were examined.
2.2. Laboratory procedures
Blood cultures were processed3 and full blood counts
(n=252) and serum biochemistry (n=375) determined
on Abx MICROSOT (Abx Hematologie) and Cobas Integra
(Roche, Basel, Switzerland) analyzers, respectively. In order
to provide a clinical service, all sera were tested with
Vidas immunoassay tests for anti-HAV IgM immunoglobu-
lin (bioMérieux, Marcy l’Etoile, France), HBsAg, anti-HBsAgpical Medicine and Hygiene 104 (2010) 475–483
(Serodia-HBs, Serodia-Anti-HBs; Fujirebio, Japan) and HCV
antibody tests (Serodia-HCV; Fujirebio, Japan). Serum sam-
pleswere stored at−80 ◦C. Sera froma subset of 51patients
with anti-HAV IgM were analysed by anti-HAV IgG avid-
ity assays and HAV PCR.6,7 The AFRIMS ELISA was used
to detect IgM and total antibody (Ig) to HEV.8,9 Acute
HEV infection was deﬁned as anti-HEV IgM≥100 Wal-
ter Reed (WR) U/ml or anti-HEV Ig ≥500 WR U/ml. Sera
from all patients with deﬁnite or probable acute HEV
were tested by HEV PCR.10 Patients positive for HBsAg
or anti-HBsAg were tested using the Murex Anti-HB IgM
ELISA kit (Abbott Laboratories, Abbott Park, IO, USA) for
IgM anti-core antigen (HBcAb). Samples from patients
with HCV antibodies were tested by HCV RNA 5′UTR
PCR using the Superscript II RT (Invitrogen) and viruses
genotyped.11 Micro-immunoﬂuorescence (IFA) assays for
Orientia, Rickettsia, Coxiella species and Neorickettsia sen-
netsu (Table 1) were considered positive if (1) positive
antibody titers were >1/128 for IgG and>1/64 for IgM, or
(2) seroconversion, or (3) four-fold or greater increase in
titers between the acute and the convalescent serum.4,12 In
microscopic agglutination tests (MAT) for Leptospira anti-
bodies, a patientwas considered to have a current or recent
Leptospira infection if serum showed a titer of ≥1:400, or
if paired sera demonstrated a four-fold rise (Table 1).13
Serum anti-dengue IgM/IgG antibodies and dengue NS1
antigen were assayed using ELISA kits (IgM/IgG Duo, Early
Dengue, PanBio, Australia) for 189 patients without a con-
ﬁrmed diagnosis.
2.3. Statistical analysis
Analysis was performed using STATA v.10 (Stata
Corp., College Station, TX, USA). Categorical variables
were compared with Fisher’s exact test and continuous
variables by Student’s t-test and Mann-Whitney U test
as appropriate. Multiple logistic regression was used to
identify predictor variable effects. A P value <0.02 was
regarded as statistically signiﬁcant.
3. Results
3.1. Patients
During the three years of the study 403 patients
were recruited; 11 were included in error (without jaun-
dice or transaminases three times the reference upper
range). Patients came predominantly from Vientiane City
(69.4%) and Vientiane Province (16.3%). The most frequent
occupations (n=391) recorded were housewife (16.9%),
unemployed (16.1%), student (15.9%), government ofﬁcial
(15.6%), building worker (14.3%) and rice farmer (8.7%).
Three hundred and seven (78.3%) patients had a history of
fever in the previous week or fever (≥37.5 ◦C) recorded on
admission. Jaundice, or a history of jaundice in the present-
ing illness, were present in 334/390 (85.6%) and 199/385
(52%) had AST and/or ALT three times or above the upper
limit of the local reference range (<37 IU/l and<40 IU/l,
respectively). Jaundice and transaminases raised at least
threefoldwere both present in 174/385 (45.2%) of patients.
A convalescent serum was taken from 204 (52%) patients
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Table 1
Serology, antigen and gene detection markers of acute jaundice/hepatitis among 392 Lao patients at Mahosot Hospital 2001–2004
Marker All patients Fever
No. positive/tested (%) No. positive/tested (%)
Hepatitis A
IgM 136/380 (35.8) 115/300 (38.3)
IgM w/o other diagnosis 110/380 (28.9) 95/300 (31.7)
Hepatitis B
HBsAg 70/389 (18.0) 50/304 (16.5)
Anti-HBsAg 61/388 (15.7) 51/303 (16.8)
Anti-IgM core 19/119 (16.0) 11/93 (11.8)
Hepatitis C
Total Ig 63/389 (16.2) 46/304 (15.1)
PCR 19/50 (38.0) 13/36 (36.1)
Hepatitis E
IgM 6/378 (1.6) 5/298 (1.7)
PCR 2/12 (17.0) 2/11 (18.2)
Dengue
IgM, IgG and NS1 33/189 (17.5) 30/139 (21.6)
Primary 14/189 (7.4) 13/139 (9.4)
Secondary 19/189 (10.0) 17/139 (12.2)
Leptospirosisa
MAT 26/385 (6.8) 24/303 (7.9)
Murine typhusb
IgM/IgG IFA 14/382 (3.7) 11/301 (3.7)
Scrub typhusc
IgM/IgG IFA 8/382 (2.1) 8/301 (2.7)
Spotted fever groupd
IgM/IgG IFA 6/382 (1.6) 5/301 (1.7)
Septicaemia
Culture positive 13/166 (7.8) 12/146 (8.2)
Ig: immunoglobulin.
a The serovars tested were Pomona, Hardjo, Tarassovi, Grippotyphosa, Celledoni, Copenhageni, Australis, Pyrogenes, Canicola, Hebdomadis, Mini, Sarmin,
Autumnalis, Cynopteri, Ballum, Bataviae, Djasiman, Javanica, Panama, Shermani and Mwalok. The serovars used in an MAT panel may not always represent
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median (range) of 6 (1–43) days after the admission
ample.
The serological, antigen-detection based and PCR-based
ssays of samples from 392 patients suggested, conserva-
ively, the following diagnoses (Table 1): hepatitis B 19/389
4.9%, IgM HBcAb positive among those HBsAg or anti-
BsAg positive), hepatitis C 19/389 (4.9%. HCV PCR and
nti-HCV positive), dengue 33/189 (17.5% or 8.4% of all
92 patients) (NS1 antigen positive and/or anti-dengue
gM/IgG positive), rickettsioses 28/382 (7.3%) (IgM/IgG
ositive), leptospirosis 26/385 (6.8%) (MAT positive), hep-
titis E 6/378 (1.6%. HEV IgM or Ig positive and/or PCR
ositive), and 13/166 (7.8% or 3.3% of all 392 patients)
ith community-acquired septicaemia. Dengue, rickettsial
nfections, leptopirosis and HAV tended to be more com-
on in the monsoon and post-monsoon months whilst
epticaemia, HBV and HCV occurred throughout the year.
Anti-HAV IgM was positive in 136 (35.8%) patients buthe age distribution (Figure 1) indicated a surprisingly high
roportionofolderpositivepatients—35%of thosepositive
ere≥40years old.Given theprior probability of high rates
f exposure and childhood infection, IgG anti-HAV avid-rogroup housing the actual serovar.
Kawasaki.
elvetica, R. honei, R. japonica, Rickettsia ‘ATI’, R. slovaca.4
ity assays were performed on sera from 51 anti-HAV IgM
positive patients; 42 (82%) patients had IgG anti-HAV avid-
ity >70%, suggesting polyclonal activation and not acute
HAV.6,7 Of the 10 patients with low IgG avidity 8 were HAV
PCR positive, whilst none of those with avidity index >70%
(42 patients) were HAV PCR positive. The HAV in all eight
PCR positive patients was genotype 1A.
Using conservative deﬁnitions of disease and excluding
HAV, 130/392 (33.2%) of patients had an aetiological diag-
nosis. Serology gave evidence for murine typhus in 14/382
(3.7%), scrub typhus in8/382 (2.1%) and spotted fever group
in 6/382 (1.6%) patients. Those with community-acquired
septicaemia grew S. Typhi in ﬁve (1.6%), E. coli in ﬁve (1.6%),
Staphylococcus aureus in two (0.6%) and Burkholderia pseu-
domallei in one (0.3%). Blood smears from the 68 patients
originating from malaria endemic areas were all negative
for Plasmodium spp. Four patients had evidence of previ-
ous infectionwith C. burnetti but no evidencewas found for
acute or chronic Q fever infection. No evidence for acute N.
sennetsu was found.
Using the conservative criteria for diagnosis of mixed
infections, 44 (11.2%) patients had evidence ofmixed infec-
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Figure 1. (A) Number of patients recruited per age category and percent age distribution of patients with anti-HAV IgM antibodies; (B) percent age
distribution of patients with anti-HBV core IgM antibodies; (C) percent age distribution of patients HCV PCR positive; (D) percent age distribution of
patients anti-leptospire MAT positive; (E) percent age distribution of patients dengue positive (IgM, IgG and/or NS1).
Table 2
Evidence for dual positivity among serology, antigen and gene detection markers of acute jaundice/hepatitis among 392 Lao patients at Mahosot Hospital,
2001–2004. SFG= spotted fever group.
HAV HBV HCV HEV Dengue Leptospirosis Scrub typhus Murine typhus SFG Sepsis
HAV 136 6 1 1 0 9 2 3 2 3
HBV 6 19 0 2 0 0 0 0 0 0
HCV 1 0 19 0 0 0 0 0 1 2
HEV 0 0 0 6 0 1 0 0 0 0
Dengue 0 0 0 0 33 0 2 1 0 1
Leptospirosis 9 0 0 1 0 26 2 0 2 1
Scrub typhus 2 0 0 0 2 2 8 0 0 0
Murine typhus 3 0 0 0 1 0 0 14 0 0
Spotted fever group 2 0 1 0 0 2 0 0 6 0
Sepsis 3 0 2 0 1 1 0 0 0 13
All (% dual) 26/136 (19%) 6/19 (32%) 4/19 (21%) 4/6 (67%) 4/33 (12%) 15/26 (58%) 6/8 (75%) 4/14 (29%) 5/6 (83%) 7/13 (54%)
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ions but the majority (61%) were HAV IgM positive (see
iscussion). Of 136 patients with anti-HAV IgM, 20% had
ther diagnoses (Table 2). The remaining apparent mixed
nfections were mostly between leptospirosis/typhus and
engue/typhus.
Past HBV infection was inferred in 61/388 (15.7%)
atientsby thepresenceof anti-HBsAgantibodies. PastHEV
nfectionwas inferred in 15.9% by the presence of anti-HEV
otal immunoglobulin without evidence of acute infection.
f the 119 patients with anti-HBsAg antibodies or HBsAg
ested for HBc IgM, the peak age group with HBc IgM was
he 25–29 year group (31%), declining to 9% in those over
0 years of age (Figure 1B). HCV antibody and PCR posi-
ive patients tended to be older: 74% of HCV PCR positive
atients were >40 years old (Figure 1C). The frequency of
atients with leptospirosis (Figure 1D) and rickettsia dif-
ered little across age groups but those positive for dengue
nfection were mostly younger: 67% were aged <30 years
Figure 1E).
The seroprevalence among 399 blood bank controls
mean (95% CI) age 22.3 (21.6–23.0) years; 80% male] of
nti-HBsAg and anti-HCV antibodies were 6.5 and 0.25%,
espectively. Of a subset of 198 controls [mean (95% CI) age
4.3 (23.3–25.4) years] anti-HEV antibodies were detected
n 18.2%. Of a subset of 162 controls [mean (95% CI) age
0.2 (19.2–21.2) years] IgM anti-HAV was detected in
one.
Two patients had serological evidence for acute HEV
nfection with HEV PCR conﬁrmation. The ﬁrst patient
as a 27 year-old non-pregnant housewife from Xaysetta
istrict, Vientiane City, with 6 days of fever and jaun-
ice. She had left upper quadrant tenderness, total serum
ilirubin 14.3mol/l, AST 55 IU/l and ALT 41 IU/l. The
econd patient was a 32 year-old construction worker
rom Sikkotabong District, Vientiane City, with four days
f fever, jaundice, and right upper quadrant pain, a his-
ory of excessive alcohol intake, total serum bilirubin
30mol/l, AST 568 IU/l and ALT 321 IU/l. He was febrile,
ith spider naevi andhepatomegaly. Bothwere discharged
ell with supportive therapy. An additional four patients
ad signiﬁcant antibodies against HEV but were HEV PCR
egative.
The 26 leptospirosis serovars as determined by MAT
ere Pomona (1), Autumnalis (5), Bataviae (4), Javanica (3),
openhageni (6), Grippotypphosa (3), Celledoni (1), Hardjo
1) and Mwalok (2). Some patients showed low level reac-
ions against multiple serovars but determination of the
nfecting serovars could not be resolved.
.2. Clinical features
Of all 392 patients the median (range) age was 34
0.4–83) years, 259 (66%) were male and 381 (97%) were
5 years or older (Supplementary Table 1). Five patients
ith scrub typhus (Kato; admission IgG 1:512, IgM 1:1024
o IgG 1:1024, IgM 1:512, 5 days later), primary dengue
anti-dengue IgM positive), hepatitis B (admission anti-
BV core IgM), hepatitis A (admission anti-HAV IgM) and
eptospirosis (MAT 1/1600 against Autumnalis) were preg-
ant. One patient had no aetiological diagnosis and none
ad acute HEV infection. All survived to discharge withpical Medicine and Hygiene 104 (2010) 475–483 479
intact pregnancies but the patient with HBV was dis-
charged moribund.
Of 389 (99%) patients with discharge information 13
(3.3%) died in hospital; six (46%) had aetiological diagnoses
of HCV infection (2), HAV infection (1), HBV infection (1),
leptospirosis (1) and scrub typhus (1).
All viral A, B, C and E hepatitis patients’ data were com-
bined and compared with those with leptospirosis, typhus,
community-acquired septicaemia and dengue. Grossly
raised transaminases was more common in the dengue
and hepatitis A, B, C and E patients whilst high bilirubin
was common for all disease categories except septicaemia
(Figure 2 A-E). The total birirubin:AST ratio and total biliru-
bin:ALT ratios were higher for patients with leptospirosis
and typhus than those with septicaemia, dengue and hep-
atitis A, B, C andE (Figure 2Dand2E). The clinical features of
the 50 (12.8%, including mixed infections) patients with an
infection expected to respond to doxycycline [leptospiro-
sis and typhus-‘doxycycline responsive illness’ (DRI)] were
similar to those with other causes of jaundice and raised
transaminases, expect that those with DRI were more
likely to have meningism (5/49, 10.2%) than those without
(6/332, 1.8%) (P=0.007). Themedian (range) ASTwas lower
in those with DRI [88 (25–337) IU/l] than in those with-
out [113 (2–1679) IU/l] and median (range) ALT was lower
in those with DRI [23 (4–164) IU/l] than in those without
[31 (2–1305) IU/l] (P=0.008 and P=0.003, respectively).
The median (range) total bilirubin:AST and bilirubin:ALT
ratios were signiﬁcantly higher in those with DRI [0.818
(0.018–9.10) and2.16 (0.116–39.48)] than in thosewithout
[0.507 (0.027–26.41) and 1.651 (0.067–66.58)] (P=0.008
and P=0.007, respectively). Applying multiple logistic
regression to the 373 patients with data onmeningism and
serumAST andALT, the odds ratios (95% CI) for DRI (against
all without known DRI) were 5.3 (1.5–18.4, P=0.009), 0.99
(0.99–1.00, P=0.15) and 0.99 (0.98–1.00, P=0.223), respec-
tively. Inclusion of the bilirubin:AST/ALT ratios did not
improve the models (P=0.9 and P=0.2, respectively). Con-
sidering those with and without leptospirosis, the median
(range) AST was lower in those with this disease [85
(25–309) IU/l] than in those without [108 (2–1679) IU/l]
(P=0.01), median (range) ALT was lower in those with
[15 (4–164) IU/l] than in those without [31 (2–1305) IU/l]
(P=0.003), the bilirubin:AST ratio was higher in those
with [1.163 (0.018-9.095)] than in those without [0.513
(0.027–26.41] (P=0.004) and the bilirubin:ALT ratio was
higher in those with [3.433 (0.171–38.048)] than in those
without leptospirosis [1.659 (0.067–66.58)] (P =0.002).
None of the potential risks factors for jaundice/hepatitis
(source of water, night soil use, past blood transfusions,
intravenous drug misuse, sexually transmitted diseases,
presence of rats, cats or pigs at home)were associatedwith
any of the diseases tested for, except that those with rick-
ettsial disease were less likely to have drunk from piped
tap water (6/28) than those with other diseases (56/120)
(P=0.01).4. Discussion
This study investigated the importance of nine viral and
bacterial diseases/syndromes in the aetiology of patients
480 B. Syhavong et al. / Transactions of the Royal Society of Tropical Medicine and Hygiene 104 (2010) 475–483
range)
tory evi
ral hepaFigure 2. Box plots (median, 25th and 75th percentiles and whiskers to
bilirubin:AST (D) and total bilirubin:ALT (E) ratios for patients with labora
fever group combined), community-acquired septicaemia, dengue and vipresenting with jaundice and/or raised transaminases
in Laos. As expected HAV, HBV, HCV and leptospirosis
were identiﬁed as important causes. HBV immunization at
birth and after has been introduced in Laos. Dengue wasfor serum AST (A), ALT (B), total bilirubin (C) concentrations and total
dence for leptospirosis, typhus (scrub typhus, murine typhus and spotted
titis A,B,C and E. Patients with mixed infections have been excluded.also common, emphasising the importance of consider-
ing dengue and appropriate speciﬁc ﬂuid management.14
That 7.8% of patients who had blood cultures drawn had
community-acquired bacteraemia, emphasises the impor-
ty of Tro
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ance of taking blood cultures in patients with biochemical
iver derangement. In a series of patients atMahosotHospi-
alwithmurine and scrub typhus, 34.6%had abnormal liver
iochemistry4 andamong462 Japanesepatientswith scrub
yphus elevated serum AST and ALT were also common
87% and 77%, respectively).15 The association of not drink-
ng tap water with rickettsial disease presumably reﬂects
hat poorer people, without taps, are at greater risk.
The limitations of the study include that, as it was hos-
ital based, it will tend to underestimate the incidence
f disease in the community, that the median interval
etween acute and convalescent sera was relatively short
t 6 days, that 48% of patients did not have a conva-
escent sample and that we did not investigate for HGV
GBV-C), parvovirus B19, syphilis, hantavirus, autoimmune
iseases, medicine adverse effects and alcohol, and few
hildren were included.1,16 This study differs from that of
ounlu et al.1 whichwas a case–control study and included
atients with <24 days of jaundice and dark urine, from
hree hospitals in Vientiane (including Mahosot Hospital).
alciparummalaria is likely tobemore important as a cause
f jaundice than suggested here in southern Laos where
alaria remains common. We included patients with both
aundice and raised transaminases as reﬂecting abnormal
iochemical liver function. However, raised bilirubin and
ransaminases can reﬂect pathology inother organs, poten-
ially confounding the results.
We used conservative deﬁnitions of disease, which
re appropriate for rickettsial disease, leptospirosis, sep-
icaemia, dengue and HEV. However, we may have missed
atientswith acuteHBVduring the corewindowasweonly
erformed HBcAb assays on patients who were HBsAg or
nti-HBsAg positive. The only method to diagnose acute
CV infection conclusively is to document seroconversion
nd some of our HCV PCR positive patients may have had
hronic, and not acute, HCV infection.17
An important ﬁnding is the description of diagnostic
roblems for HAV for the ﬁrst time in the tropics.6,7 Anti-
AV IgM, conventionally considered the gold standard
or the diagnosis of acute HAV, persists for 3 months–5
ears.18 However, HAV IgM can result from nonspeciﬁc
olyclonal activation of memory cells and positive results
ot reﬂecting acute HAV infection may be more common
han previously appreciated.6,7,19 The HAV IgG avidity and
CR analysis suggest that the majority of positive anti-
AV IgM results did not represent acute HAV infection but
olyclonal activation. This is supported by the relatively
ow median transaminases in those with apparent HAV
Supplementary Table 1, Figure 2A and 2B) and the absence
f anti-HAV IgM in blood donors. Hence, we are unable to
rovide a secure estimate of the incidence of acute HAV
n this cohort. The diagnosis of HAV using IgM antibodies
eeds review and investigation of the causes of polyclonal
ctivation. The predominant subgenotype in adjacent Thai-
and is also 1A.20
HEV has been described from adjacent countries21 and
he six patients described here are the ﬁrst conﬁrmed
rom Laos. HEV infections are common in Lao domestic
igs22 and, if human HEV infections are contracted from
igs, HEV is likely to be a more important disease in rural
aos.pical Medicine and Hygiene 104 (2010) 475–483 481
In adjacent northeast Thailand, HCV antibodies were
detected in 6.5% of male (0.9% of female) blood donors
and the prevalence of HBsAg was 4.9%. Of HCV antibody
positive blood donors 80.4% were viraemic.23 In adjacent
northern Vietnam, of 188 patients with clinical hepati-
tis, there was serological evidence for HAV in 29%, HBV
in 24%, HCV in 10% with no evidence for acute HEV.24
Of HCV from 18 Lao patients in this study all were geno-
type 6, which has also been recorded in east and Southeast
Asia.11 Although we found no evidence for acute C. bur-
netii infection, this has been recently described innortheast
Thailand.25 In 1999–2003 a large epidemic of leptospirosis
afﬂicted northeast Thailand, caused by Serotype 34 Lep-
tospira interrogans serovar Autumnalis.26 However, only
5/26 (19%) of leptospira isolates from patients in Vien-
tiane, 70kmfromthestudysiteofThaipadungpanit,26 were
Autumnalis. No epidemics of undifferentiated fever, such
as occurred in adjacent areas of northeast Thailand, appear
to have occurred in/around Vientiane. The Mekong River,
which forms the Laos/Thai border in central Laos with
only one bridge at the time of the study, may therefore
have acted as an effective barrier preventing the signiﬁ-
cant spread of rats and the epidemic Leptospira clone into
Laos.
The interpretation of apparent mixed infections, espe-
ciallywhenbasedonserology for clinically similardiseases,
is difﬁcult. Given the difﬁculties demonstrated in the diag-
nosis of acute HAV, the apparent mixed infections with
HAV may represent false HAV positivity. Those between
leptospirosis and typhus and between dengue and typhus
may represent serial infections with persistence of anti-
body, false positivity or genuine mixed infections. More
research is required, using culture and antigen and gene
detection tests, to tease out the relative frequency of these
explanations in the Asiatic tropics.
Of the diagnoses entertained here, only leptospirosis,
typhus and septicaemia, or 62 (15.8%, including mixed
infections) patients, have speciﬁc affordable treatments
available. In Thailand the current cost of treating HBV and
HCV infections are approximately US$1000 and US$1250
a month, respectively. With a Laos per capita income of
US$701 a year these are not affordable.27 Therefore, in the
absence of locally accessible diagnostic tests and antiviral
therapy in the vastmajority of Laos, empirical therapywith
doxycycline may be a cost-effective treatment with signif-
icant public health beneﬁts for the 12.8% of patients with
a DRI; these are currently the only patients with a poten-
tially treatable disease. Those with a DRI represent 39% of
all patientswith a diagnosis and, excluding thosewith sep-
ticaemia, for the remaining 52% patients with a diagnosis,
therapy is unavailable or unaffordable. A DRI is suggested
by meningism and relatively low ALT (none of the patients
with DRI had an ALT >164 IU/l). However, as transaminases
assays are rarely available in Laos and relatively expensive
(US$3.5 a test), empirical therapy for febrile jaundice with
doxycycline may be cost effective, as the cost of a 7 day
oral course of doxycycline is only approximately US$0.9
and is available in rural Laos. The available data suggest
that doxycycline is safe in liver impairment.28 There is
evidence that oral doxycycline, providedpatients can swal-
low, is effective in severe leptospirosis and probably in
ty of Tro482 B. Syhavong et al. / Transactions of the Royal Socie
severe typhus.29,30 However, doxycycline adverse effects,
especially to the upper gastrointestinal tract, are frequent
andwould reduce the positive public health impact of such
an intervention.
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